Literature DB >> 24155261

Pharmacological properties of shikonin - a review of literature since 2002.

Isabel Andújar1, José Luis Ríos1, Rosa María Giner1, María Carmen Recio1.   

Abstract

The naphthoquinone shikonin is the main active principle of Zicao, a traditional Chinese herbal medicine made from the dried root of Lithospermum erythrorhizon. Studies carried out over the past 30 years have provided a scientific basis for the use of Zicao which has been long employed in folk medicine to treat a variety of inflammatory and infectious diseases. In particular, shikonin has been shown to possess many diverse properties, including antioxidant, anti-inflammatory, antithrombotic, antimicrobial, and wound healing effects. The fact that shikonin shows so many beneficial properties has increased the interest in this molecule dramatically, especially in the past few years. The aim of this review is to provide an update of the new data published on shikonin, whose wide spectrum of pharmacological effects as well as pharmacokinetic properties and toxicity make it a highly interesting target molecule. Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24155261     DOI: 10.1055/s-0033-1350934

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  82 in total

1.  CYP76B74 Catalyzes the 3''-Hydroxylation of Geranylhydroquinone in Shikonin Biosynthesis.

Authors:  Sheng Wang; Ruishan Wang; Tan Liu; Chaogeng Lv; Jiuwen Liang; Chuanzhi Kang; Liangyun Zhou; Juan Guo; Guanghong Cui; Yan Zhang; Daniele Werck-Reichhart; Lanping Guo; Luqi Huang
Journal:  Plant Physiol       Date:  2018-11-29       Impact factor: 8.340

2.  Shikonin changes the lipopolysaccharide-induced expression of inflammation-related genes in macrophages.

Authors:  Lucia Satiko Yoshida; Tomohito Kakegawa; Yasukatsu Yuda; Hiromi Takano-Ohmuro
Journal:  J Nat Med       Date:  2017-07-11       Impact factor: 2.343

3.  Shikonin promotes osteogenesis and suppresses osteoclastogenesis in vitro.

Authors:  Liang Zhou; Jiaqian Wang; Jiali Zhao; Feng Kuai; Huilin Yang
Journal:  Am J Transl Res       Date:  2020-12-15       Impact factor: 4.060

4.  Shikonin inhibits invasiveness of osteosarcoma through MMP13 suppression.

Authors:  Biyong Deng; Bing Qiu
Journal:  Tumour Biol       Date:  2015-06-24

Review 5.  Anticancer Effects of Constituents of Herbs Targeting Osteosarcoma.

Authors:  Qing-Hong Su; Xiao-Qun Xu; Jun-Fu Wang; Jun-Wen Luan; Xia Ren; Hai-Yan Huang; Si-Shan Bian
Journal:  Chin J Integr Med       Date:  2019-06-04       Impact factor: 1.978

6.  Homocysteine Activates B Cells via Regulating PKM2-Dependent Metabolic Reprogramming.

Authors:  Jiacheng Deng; Silin Lü; Huiying Liu; Bo Liu; Changtao Jiang; Qingbo Xu; Juan Feng; Xian Wang
Journal:  J Immunol       Date:  2016-11-30       Impact factor: 5.422

7.  Acetylshikonin from Zicao ameliorates renal dysfunction and fibrosis in diabetic mice by inhibiting TGF-β1/Smad pathway.

Authors:  Zezhao Li; Zhen Hong; Zhiqing Peng; Yongcai Zhao; Rusheng Shao
Journal:  Hum Cell       Date:  2018-03-17       Impact factor: 4.174

8.  Shikonin inhibits myeloid differentiation protein 2 to prevent LPS-induced acute lung injury.

Authors:  Yali Zhang; Tingting Xu; Zheer Pan; Xiangting Ge; Chuchu Sun; Chun Lu; Hongjin Chen; Zhongxiang Xiao; Bing Zhang; Yuanrong Dai; Guang Liang
Journal:  Br J Pharmacol       Date:  2018-01-25       Impact factor: 8.739

Review 9.  Competitive glucose metabolism as a target to boost bladder cancer immunotherapy.

Authors:  Julieta Afonso; Lúcio L Santos; Adhemar Longatto-Filho; Fátima Baltazar
Journal:  Nat Rev Urol       Date:  2020-01-17       Impact factor: 14.432

Review 10.  Medicinal Plants and Isolated Molecules Demonstrating Immunomodulation Activity as Potential Alternative Therapies for Viral Diseases Including COVID-19.

Authors:  Hassan A Alhazmi; Asim Najmi; Sadique A Javed; Shahnaz Sultana; Mohammed Al Bratty; Hafiz A Makeen; Abdulkarim M Meraya; Waquar Ahsan; Syam Mohan; Manal M E Taha; Asaad Khalid
Journal:  Front Immunol       Date:  2021-05-13       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.